HLS Therapeutics Inc. (TSX:HLS)
Canada flag Canada · Delayed Price · Currency is CAD
4.430
+0.030 (0.68%)
Apr 10, 2026, 3:59 PM EST

HLS Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
142151125126318487
Market Cap Growth
1.26%20.52%-1.00%-60.28%-34.71%-15.01%
Enterprise Value
194.53205.26196.49217.91425.51586.92
Last Close Price
4.434.823.933.959.8215.00
PE Ratio
--9.00-4.42-3.51-9.92-28.95
PS Ratio
1.871.981.541.513.816.42
PB Ratio
1.681.781.220.981.872.40
P/TBV Ratio
2.272.461.761.302.543.00
P/FCF Ratio
6.136.4910.916.0513.8623.51
P/OCF Ratio
6.066.4110.896.0413.8323.45
EV/Sales Ratio
2.562.692.422.615.107.74
EV/EBITDA Ratio
8.019.167.8610.7019.9519.50
EV/EBIT Ratio
--27.27-25.89-9.93-16.79-71.96
EV/FCF Ratio
8.388.8417.1410.4418.5628.35
Debt / Equity Ratio
0.840.840.940.930.800.62
Debt / EBITDA Ratio
3.153.153.865.936.364.21
Debt / FCF Ratio
3.043.048.425.795.926.13
Net Debt / Equity Ratio
0.650.650.700.710.630.49
Net Debt / EBITDA Ratio
2.442.442.864.505.053.33
Net Debt / FCF Ratio
2.352.356.244.394.704.83
Asset Turnover
0.370.370.310.280.240.21
Inventory Turnover
1.171.170.970.830.560.41
Quick Ratio
0.750.751.101.221.021.18
Current Ratio
1.111.111.571.651.421.58
Return on Equity (ROE)
-18.69%-18.69%-23.26%-24.69%-16.50%-7.95%
Return on Assets (ROA)
-3.56%-3.56%-3.62%-7.28%-7.18%-2.47%
Return on Invested Capital (ROIC)
-4.25%-4.25%-4.35%-8.61%-8.22%-2.79%
Return on Capital Employed (ROCE)
-4.41%-4.41%-3.31%-8.43%-8.15%-2.50%
Earnings Yield
-11.98%-11.11%-22.63%-28.52%-10.08%-3.45%
FCF Yield
16.31%15.42%9.17%16.52%7.21%4.25%
Dividend Yield
-0.00%0.00%2.49%2.11%1.34%
Payout Ratio
-0.00%0.00%-8.71%-21.03%-39.05%
Buyback Yield / Dilution
0.98%0.98%1.31%0.52%-0.77%-1.48%
Total Shareholder Return
0.98%0.98%1.31%3.02%1.34%-0.14%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.